KASEY MAYS: Open Payments
NPI 1083288666 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 28 payments from 8 companies in 2025. Trend: 2023 $458 · 2024 $530 · 2025 $515
Food & beverage: $476Education: $39
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $142 |
| Aurinia Pharma U.S., Inc. | 4 | $97 |
| Apellis Pharmaceuticals, Inc. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| OPKO Pharmaceuticals, LLC | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Calliditas Therapeutics US Inc. | 1 | $26 |
| Travere Therapeutics, Inc. | 4 | $24 |
Products named: Kerendia, LUPKYNIS, FARXIGA, RAYALDEE, JARDIANCE, Empaveli, TARPEYO, Filspari.
Industry payments across GA — which companies pay providers there.
